Breast Cancer Trial, Recruiting NCT06977360 Sponsor: National Cancer Centre, Singapore Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06977360
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women who are 21 years of age or older at the time of joining the trial
  • Women who have been diagnosed with stage 1, 2, or 3 breast cancer
  • Women who are beginning chemotherapy for the first time, including those who have had up to 4 cycles so far
  • Women who can speak, read, and write in English or Mandarin
  • Women who own a smartphone and are able to use it

Who may not be able to join:

  • Women who have had, or currently have, any other type of cancer besides breast cancer
  • Women who have been diagnosed with a psychiatric condition (such as schizophrenia), an anxiety disorder, another mood disorder, or a condition affecting memory or thinking
  • Women who have had problems with alcohol or drug misuse in the past year
  • Women who are currently taking part in another program focused on emotional or psychological support
  • Women who have experienced the death of a loved one within the last 6 months
  • Women who are currently pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 8 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Dr Ryan Shea YC Tan, MBBS, MRCP(UK), MMed, National Cancer Centre, Singapore

Phone: +65 64368000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
National Cancer Centre, Singapore
Registry
ClinicalTrials.gov
Start date
23 May 2025
Est. completion
31 October 2025

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

The feasibility of research method and Intervention; The acceptability of intervention; The impact of psychosocial intervention (iCareBreast+ app) on cancer self-efficacy; The impact of psychosocial Intervention (iCareBreast+ app) on knowledge of breast cancer treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov